Features, Transmission, Detection, and Case Studies in COVID-19

Section A: SARS-CoV-2 and COVID-19: Introductory chapters and setting the scene<br><br>1. Coronavirus disease 2019 (COVID-19) pandemic in context: Systemic effects<br><br>2. Early warning of SARS-CoV-2 infection<br><br>3. Mobile phones and their use to study dynamics of the COVID-19 pandemic<br><br>Section B: Structure, transmission and avoidance<br><br>4. Cis regulatory elements: A novel communication route between the host cell and the SARS-CoV-2 genome<br><br>5. SARS-CoV-2 ORF8: Structure, evolution, molecular function, and its contribution to the<br>pathogenicity of the virus<br><br>6. SARS-CoV-2 spike protein binding ligands and its application in COVID-19 therapeutics<br><br>7. SARS-CoV-2 bulldozes the autophagy pathway and unhinges mitochondrial quality control<br>thereby driving neurodegeneration—A hypothesis<br><br>8. The Omicron variant of SARS-CoV-2<br><br>9. Monitoring SARS-CoV-2 spread in hospitals<br><br>10. Computational analysis of mutations in SARS-CoV-2 variants spike protein and protein<br>interactions<br><br>11. Airborne transmission of SARS-CoV-2<br><br>12. Reducing transmission of SARS-CoV-2 with face masks: Its potential protective effects<br><br>13. Digital twin of ventilation system against COVID-19 transmission and infection risk<br><br>14. Pets and SARS-CoV-2: What is their role in the epidemiology of the disease?<br><br>15. SARS-CoV-2 transmission in dental practice<br><br>16. SARS-CoV-2 compared with influenza and respiratory syncytial virus in terms of vertical<br>transmission<br><br>17. Reducing droplets and aerosols in the surgical setting and applications to the COVID-19<br>pandemic<br><br>18. SARS-CoV motion dynamics: Linking in droplet size<br><br>19. Ventilation and airborne particles in classrooms: Implications for the COVID-19 pandemic<br><br>20. Indoor transmission of the SARS-CoV-2 virus through aerosols emitted by e-cigarettes<br><br>Section C: Impact and effects<br><br>21. The Impact of COVID-19 on first responders<br><br>22. COVID-19 and suspected drug-induced liver injury<br><br>23. Pulmonary fibrosis in COVID-19<br><br>24. The effect of SARS-CoV-2 infection on cancer: Clinical correlation and<br>potential pathological mechanism<br><br>25. Severe SARS-CoV-2, plateletendothelium interactions, and cardiovascular injury<br><br>26. Cardiometabolic syndrome and COVID-19: Pathophysiological aspects<br><br>27. COVID-19 and type 1 and 2 diabetes: An overview<br><br>28. COVID-19 and older adults: An overview<br><br>29. COVID-19 and male fertility<br><br>30. COVID-19 and obesity: An overview<br><br>Section D: Treatments, strategies, and vaccines<br><br>31. COVD-19 vaccines and their impact: An overview<br><br>32. Exploring the promise of COVID-19 vaccines: A review of preclinical studies<br><br>33. Drugs actively being investigated for use in COVID-19<br><br>34. The biology of neutralizing antibody therapy with REGEN-COV<br><br>35. The intensive care unit and percutaneous tracheostomy in patients with coronavirus disease<br>2019<br><br>36. Cardiac effects of drugs and vaccines used to treat and prevent COVID-19<br><br>37. COVID-19 pandemic and isolation: Impact on sleep<br><br>38. Strategies in the COVID-19 pandemic: Disinfection of gloved hands<br><br>39. In silico studies on established antivirals on SARS-CoV-2 RNAdependent RNA polymerase<br><br>40. The COVID-19 cytokine storm and its immunomodulatory treatment<br><br>41. Safety and efficacy of nebulization for reducing the intensity of viral load and clinical manifestations in patients with COVID-19<br><br>Section E: Detection and biomarkers<br><br>42. Bronchoalveolar lavage (BAL) and use in detection of SARS-CoV-2<br><br>43. SARS-CoV-2 testing and vaccination among people who use drugs<br><br>44. Homocysteine as a biomarker in COVID-19<br><br>45. Assessment of smell and taste in COVID-19<br><br>46. S-gene analysis: RT-PCR and Sanger sequencing applied to SARS-CoV-2 virus<br><br>47. False-negative results in screening for SARS-CoV-2<br><br>48. Sample pooling and SARS-CoV-2 assays<br><br>49. Biomarkers of invasive mechanical ventilation in obesity and metabolic syndrome in patients<br>with COVID-19<br><br>Section F: Case studies with mini review<br><br>50. Hypoxia and heart-lung interactions in COVID-19: The significance of right heart dysfunction and shunt<br><br>51. Ulnar nerve dysfunction as COVID-19 sequelae<br><br>52. Case study: Coronavirus disease 2019 and acute kidney injury<br><br>53. Case study: The detection and treatment of a pneumothorax in a patient with coronavirus disease 2019 pneumonia<br><br>54. Proposal and demonstration of a survey method for the prevention of airborne transmission: Case studies in healthcare and welfare facilities<br><br>Section G: Resources<br><br>55. Recommended resources for the features, transmission, and detection of coronavirus disease<br>2019 (COVID-19)